{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:49:13Z","timestamp":1792586953315,"version":"4.5.0"},"reference-count":37,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70642","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:07:15Z","timestamp":1780787235000},"source":"Crossref","is-referenced-by-count":0,"title":["Haemoperfusion Combined With Xuebijing Injection Improves Inflammatory Status And Prognosis In Patients With End-Stage Renal Disease"],"prefix":"10.3791","author":[{"given":"Fangqian","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"800950","DOI":"10.3389\/fphar.2022.800950","type":"journal-article","article-title":"Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease","volume":"13","author":"Wang","year":"2022","unstructured":"Wang, Y., Gao, L. Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease. Front Pharmacol. 13, 800950 (2022).","journal-title":"Front Pharmacol"},{"issue":"10","key":"ref2","first-page":"1","type":"journal-article","article-title":"Kidney: A Review on End Stage Renal Disease","volume":"8","author":"Palleti","year":"2023","unstructured":"Palleti, SK., Avula, S., Dewan, S. Kidney: A Review on End Stage Renal Disease. Int Clinc Med Case Rep Jour. 8 (10), 1\u20138 (2023).","journal-title":"Int Clinc Med Case Rep Jour"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/jcm11061584","type":"journal-article","article-title":"Quality of life in patients with end-stage renal disease undergoing hemodialysis","volume":"11","author":"Dembowska","year":"2022","unstructured":"Dembowska, E., et al. Quality of life in patients with end-stage renal disease undergoing hemodialysis. J Clin Med. 11 (6), 1584 (2022).","journal-title":"J Clin Med"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/aor.14396","type":"journal-article","article-title":"Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: current status and review","volume":"47","author":"Groth","year":"2023","unstructured":"Groth, T., et al. Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: current status and review. Artif Organs. 47 (4), 649\u2013666 (2023).","journal-title":"Artif Organs"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"e0261941","DOI":"10.1371\/journal.pone.0261941","type":"journal-article","article-title":"The experience of urgent dialysis patients with end-stage renal disease: a qualitative study","volume":"17","author":"Lin","year":"2022","unstructured":"Lin, M., Chu, K. The experience of urgent dialysis patients with end-stage renal disease: a qualitative study. Plos One. 17 (1), e0261941 (2022).","journal-title":"Plos One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"832924","DOI":"10.3389\/fimmu.2022.832924","type":"journal-article","article-title":"Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis, and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine","volume":"13","author":"Piotrowska","year":"2022","unstructured":"Piotrowska, M., et al. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis, and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine. Front Immunol. 13, 832924 (2022).","journal-title":"Front Immunol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ejhf.2471","type":"journal-article","article-title":"Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Mullens","year":"2022","unstructured":"Mullens, W., et al. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 24 (4), 603\u2013619 (2022).","journal-title":"Eur J Heart Fail"},{"key":"ref8","first-page":"545262","type":"journal-article","article-title":"The clinical efficacy evaluation of the KHA-200 hemoperfusion device in the treatment of end-stage renal disease patients undergoing blood purification therapy","volume":"29","author":"Yang","year":"2025","unstructured":"Yang, Q., et al. The clinical efficacy evaluation of the KHA-200 hemoperfusion device in the treatment of end-stage renal disease patients undergoing blood purification therapy. Kidney Diseases. 29, 545262 (2025).","journal-title":"Kidney Diseases"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000514187","type":"journal-article","article-title":"Survival outcomes of hemoperfusion and hemodialysis versus hemodialysis in patients with end-stage renal disease: a systematic review and meta-analysis","volume":"51","author":"Cheng","year":"2022","unstructured":"Cheng, W., et al. Survival outcomes of hemoperfusion and hemodialysis versus hemodialysis in patients with end-stage renal disease: a systematic review and meta-analysis. Blood Purification. 51 (3), 213\u2013225 (2022).","journal-title":"Blood Purification"},{"key":"ref10","first-page":"118","type":"journal-article","article-title":"Combined hemoperfusion-hemodialysis in end-stage renal disease patients","volume":"200","author":"Roncoa","year":"2023","unstructured":"Roncoa C. Combined hemoperfusion-hemodialysis in end-stage renal disease patients. Adsorption: The New Frontier in Extracorporeal Blood Purification. 200, 118\u2013122 (2023).","journal-title":"Adsorption: The New Frontier in Extracorporeal Blood Purification"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"113301","DOI":"10.1016\/j.jep.2020.113301","type":"journal-article","article-title":"The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies, and potential mechanisms","volume":"265","author":"Li","year":"2021","unstructured":"Li, C., et al. The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies, and potential mechanisms. J Ethnopharmacol. 265, 113301 (2021).","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/CCM.0000000000003842","type":"journal-article","article-title":"XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial","volume":"47","author":"Song","year":"2019","unstructured":"Song, Y., et al. XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial. Crit Care Med. 47 (9), 735\u2013743 (2019).","journal-title":"Crit Care Med"},{"issue":"4","key":"ref13","first-page":"56","type":"journal-article","article-title":"Effects of Changtuoning and Xuebijing combined with hemoperfusion on serum inflammatory factors and myocardial enzymes in patients with acute severe organophosphorus poisoning","volume":"25","author":"Ma","year":"2019","unstructured":"Ma, L., Wang, X. Effects of Changtuoning and Xuebijing combined with hemoperfusion on serum inflammatory factors and myocardial enzymes in patients with acute severe organophosphorus poisoning. J Hainan Med Univ. 25 (4), 56\u201360 (2019).","journal-title":"J Hainan Med Univ"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ckj\/sfad179","type":"journal-article","article-title":"Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis","volume":"17","author":"Pisano","year":"2024","unstructured":"Pisano, A., Zoccali, C., Bolignano, D., D'Arrigo, G., Mallamaci, F. Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis. Clin Kidney J. 17 (1), 179 .(2024).","journal-title":"Clin Kidney J"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/iej.13786","type":"journal-article","article-title":"The impact of apical periodontitis, non-surgical root canal retreatment, and periapical surgery on serum inflammatory biomarkers","volume":"55","author":"Bakhsh","year":"2022","unstructured":"Bakhsh, A., Moyes, D., Proctor, G., Mannocci, F., Niazi, SA. The impact of apical periodontitis, non-surgical root canal retreatment, and periapical surgery on serum inflammatory biomarkers. Int Endod J. 55 (9), 923\u2013937 (2022).","journal-title":"Int Endod J"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1515\/cclm-2020-0548","type":"journal-article","article-title":"Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays","volume":"58","author":"Qian","year":"2020","unstructured":"Qian, C., et al. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays. Clin Chem Lab Med. 58 (9), 1601\u20131607 (2020).","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/labmed-2020-0115","type":"journal-article","article-title":"Correlations of serum beta 2-microglobulin level with disease activity and renal involvement in patients with systemic lupus erythematosus","volume":"45","author":"Liu","year":"2021","unstructured":"Liu, B., Lu, F., Lin, J., Zou, H. Correlations of serum beta 2-microglobulin level with disease activity and renal involvement in patients with systemic lupus erythematosus. Journal of Laboratory Medicine. 45 (1), 13\u201318 (2021).","journal-title":"Journal of Laboratory Medicine"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s11136-021-03019-5","type":"journal-article","article-title":"Psychopathology and health-related quality of life as patient-reported treatment outcomes: evaluation of concordance between the Brief Symptom Inventory (BSI) and the Short Form-36 (SF-36) in psychiatric outpatients","volume":"31","author":"de Beurs","year":"2022","unstructured":"de Beurs, E., Carlier, I., van Hemert, A. Psychopathology and health-related quality of life as patient-reported treatment outcomes: evaluation of concordance between the Brief Symptom Inventory (BSI) and the Short Form-36 (SF-36) in psychiatric outpatients. Quality of Life Research. 31 (5), 1461\u20131471 (2022).","journal-title":"Quality of Life Research"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3390\/ijerph19042389","type":"journal-article","article-title":"Cognitive Impairment in End Stage Renal Disease Patients Undergoing Hemodialysis: Markers and Risk Factors","volume":"19","author":"Olczyk","year":"2022","unstructured":"Olczyk, P., Kusztal, M., Go\u0142\u0119biowski, T., Letachowicz, K., Krajewska, M. Cognitive Impairment in End Stage Renal Disease Patients Undergoing Hemodialysis: Markers and Risk Factors. Int J Environ Res Public Health. 19 (4), 2389 (2022).","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/ijerph19031436","type":"journal-article","article-title":"Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease","volume":"19","author":"Rogula","year":"2022","unstructured":"Rogula, S., et al. Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease. Int J Environ Res Public Health. 19 (3), 1436 (2022).","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.121.052792","type":"journal-article","article-title":"Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease","volume":"145","author":"Beldhuis","year":"2022","unstructured":"Beldhuis, IE., et al. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease. Circulation. 145(9), 693\u2013712 .(2022).","journal-title":"Circulation"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1159\/000525225","type":"journal-article","article-title":"Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic Pruritus","volume":"51","author":"Zhao","year":"2022","unstructured":"Zhao D., et al. Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic Pruritus. Blood Purification. 51 (10), 812\u2013822 (2022).","journal-title":"Blood Purification"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.23876\/j.krcp.22.223","type":"journal-article","article-title":"Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility","volume":"42","author":"Damianaki","year":"2023","unstructured":"Damianaki, A., Stambolliu, E., Alexakou, Z., Petras, D. Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility. Kidney Res Clin Pract. 42 (3), 298\u2013311 (2023).","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13054-022-04009-w","type":"journal-article","article-title":"Hemoperfusion: technical aspects and state of the art","volume":"26","author":"Ronco","year":"2022","unstructured":"Ronco, C., Bellomo, R. Hemoperfusion: technical aspects and state of the art. Critical Care. 26 (1), 135 (2022).","journal-title":"Critical Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1413597","DOI":"10.3389\/fphar.2025.1413597","type":"journal-article","article-title":"XueBiJing injection reduced mortality in sepsis patients with diabetes","volume":"16","author":"Liu","year":"2025","unstructured":"Liu, Y., et al. XueBiJing injection reduced mortality in sepsis patients with diabetes. Front Pharmacol. 16, 1413597 .(2025).","journal-title":"Front Pharmacol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.18632\/aging.204740","type":"journal-article","article-title":"Xuebijing injection protects against sepsis-induced myocardial injury by regulating apoptosis and autophagy via mediation of PI3K\/AKT\/mTOR signaling pathway in rats","volume":"15","author":"Bi","year":"2023","unstructured":"Bi, CF., et al. Xuebijing injection protects against sepsis-induced myocardial injury by regulating apoptosis and autophagy via mediation of PI3K\/AKT\/mTOR signaling pathway in rats. Aging. 15 (10), 4374\u20134390 (2023).","journal-title":"Aging"},{"issue":"15","key":"ref27","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.3390\/ijerph19158987","type":"journal-article","article-title":"A randomized controlled trial evaluating the levels of the biomarkers hs-CRP, IL-6, and IL-8 in patients with temporomandibular disorder treated with LLLT, traditional conservative treatment, and a combination of both","volume":"19","author":"Zwiri","year":"2022","unstructured":"Zwiri, AM., et al. A randomized controlled trial evaluating the levels of the biomarkers hs-CRP, IL-6, and IL-8 in patients with temporomandibular disorder treated with LLLT, traditional conservative treatment, and a combination of both. Int J Environ Res Public Health. 19 (15), 8987 (2022).","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.63623\/9k14tf70","type":"journal-article","article-title":"Advances in Combination Therapy for Gastric Cancer: Integrating Targeted Agents and Immunotherapy","volume":"1","author":"Ren","year":"2024","unstructured":"Ren, J. Advances in Combination Therapy for Gastric Cancer: Integrating Targeted Agents and Immunotherapy. Adv Clin Pharmacol Ther. 1 (1), 1\u201315 (2024).","journal-title":"Adv Clin Pharmacol Ther"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"7650713","DOI":"10.1155\/2020\/7650713","type":"journal-article","article-title":"Association of the neutrophil\u2013lymphocyte ratio and the presence of neonatal sepsis","volume":"2020","author":"Li","year":"2020","unstructured":"Li, T., et al. Association of the neutrophil\u2013lymphocyte ratio and the presence of neonatal sepsis. J Immunol Res. 2020 (1), 7650713 (2020).","journal-title":"J Immunol Res"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.62382\/jcbt.v2i2.53","type":"journal-article","article-title":"The miRNA-9 Isoform Story in Cancer: An OncomiR or Tumor Suppressor?","volume":"2","author":"Mahmoud","year":"2025","unstructured":"Mahmoud, I., et al. The miRNA-9 Isoform Story in Cancer: An OncomiR or Tumor Suppressor? J Can Biomol Therap. 2 (2), 13\u201336 (2025).","journal-title":"J Can Biomol Therap"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1016877","DOI":"10.3389\/fimmu.2022.1016877","type":"journal-article","article-title":"Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?","volume":"13","author":"Beudeker","year":"2022","unstructured":"Beudeker, CR., Vijlbrief, DC., van Montfrans, JM., Rooijakkers, SH., Flier, Mvd. Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies? Front Immunol. 13, 1016877 (2022).","journal-title":"Front Immunol"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"e081485","DOI":"10.1136\/bmjopen-2023-081485","type":"journal-article","article-title":"New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province","volume":"14","author":"Zhao","year":"2024","unstructured":"Zhao, Z., et al. New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province. BMJ Open. 14 (8), e081485 (2024).","journal-title":"BMJ Open"},{"issue":"17","key":"ref33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/ars.2020.8184","type":"journal-article","article-title":"Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients","volume":"35","author":"Ebert","year":"2021","unstructured":"Ebert, T., Neytchev, O., Witasp, A., Kublickiene, K., Stenvinkel, P., Shiels, PG. Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients. Antioxid Redox Signal. 35 (17), 1426\u20131448 (2021).","journal-title":"Antioxid Redox Signal"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1335094","DOI":"10.3389\/fphar.2023.1335094","type":"journal-article","article-title":"The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis","volume":"14","author":"Ren","year":"2024","unstructured":"Ren, N., Wang, W., Zou, L., Zhao, Y., Miao, H., Zhao, Y. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis. Front Pharmacol. 14, 1335094 .(2024).","journal-title":"Front Pharmacol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cei.13119","type":"journal-article","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","unstructured":"Tecklenborg, J., Clayton, D., Siebert, S., Coley, SM. The role of the immune system in kidney disease. Clin Exp Immunol. 192 (2), 142\u2013150 (2018).","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"e12763","DOI":"10.1111\/cpr.12763","type":"journal-article","article-title":"Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease","volume":"53","author":"Chen","year":"2020","unstructured":"Chen, S., Lv, L., Liu, B., Tang, R. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease. Cell Proliferation. 53 (3), e12763 (2020).","journal-title":"Cell Proliferation"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"2471016","DOI":"10.1080\/0886022X.2025.2471016","type":"journal-article","article-title":"The association between nutritional-inflammatory status and chronic kidney disease prognosis: a population-based study","volume":"47","author":"Zhang","year":"2025","unstructured":"Zhang, X., et al. The association between nutritional-inflammatory status and chronic kidney disease prognosis: a population-based study. Renal Failure. 47 (1), 2471016 (2025).","journal-title":"Renal Failure"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70642\/haemoperfusion-combined-with-xuebijing-injection-improves","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:33:49Z","timestamp":1792586029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70642\/haemoperfusion-combined-with-xuebijing-injection-improves"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":37,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70642","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}